Literature DB >> 21377585

Planning and follow-up after ablation of hepatic tumors: imaging evaluation.

Piyaporn Boonsirikamchai1, Evelyne M Loyer, Haesun Choi, Chusilp Charnsangavej.   

Abstract

CTs or MRIs are essential for preablative therapy planning of hepatic tumors to identify accurate size, number, and location of tumors. Tumors larger than 5 cm and located near the major branches of the portal vein and hepatic vein have a higher potential for incomplete ablation. Postablative imaging studies are needed to determine if the entire tumors are included in the treatment zone to minimize the risk of local tumor recurrences. Complications of ablative therapy can be identified on post-treatment imaging studies. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21377585     DOI: 10.1016/j.soc.2010.11.007

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  4 in total

Review 1.  Primary hepatic neuroendocrine tumor with multiple liver metastases: A case report with review of the literature.

Authors:  Kai Yang; Ying-Sheng Cheng; Ji-Jin Yang; Xu Jiang; Ji-Xiang Guo
Journal:  World J Gastroenterol       Date:  2015-03-14       Impact factor: 5.742

2.  Radiofrequency Ablation of Hepatic Tumor: Subjective Assessment of the Perilesional Vascular Network on Contrast-Enhanced Computed Tomography Before and After Ablation Can Reliably Predict the Risk of Local Recurrence.

Authors:  Sireesha Yedururi; Silanath Terpenning; Sanjay Gupta; Patricia Fox; Sooyoung Shin Martin; Claudius Conrad; Evelyne M Loyer
Journal:  J Comput Assist Tomogr       Date:  2017 Jul/Aug       Impact factor: 1.826

3.  Evaluation of cancer treatment in the abdomen: Trends and advances.

Authors:  Silanath Peungjesada; Hubert H Chuang; Srinivasa R Prasad; Haesun Choi; Evelyne M Loyer; Yulia Bronstein
Journal:  World J Radiol       Date:  2013-03-28

4.  Primary hepatic neuroendocrine tumor: A case report.

Authors:  Asahiro Morishita; Hirohito Yoneyama; Takako Nomura; Teppei Sakamoto; Koji Fujita; Joji Tani; Hisaaki Miyoshi; Reiji Haba; Tsutomu Masaki
Journal:  Mol Clin Oncol       Date:  2016-03-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.